Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Male pattern baldness may be linked to prostate cancer risk.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Long-term diabetes is linked to lower prostate cancer risk.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Higher DHT in male baldness may protect against prostate cancer.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.